|
|
cas 5747-48-8 |
CLASS NERVOUS SYSTEM ANTIPSYCHOTIC SCHIZOPHRENIA DIBENZOTHIAZEPINE FAMILY DOPAMINE D2 RECEPTOR ANTAGONIST (IC50=329 NANOMOLAR) SEROTONIN (5HT2) ANTAGONIST (IC50=148 NANOMOLAR) SEROTONIN 5HT1A ANTAGONIST (IC50=717 NANOMOLAR) DOPAMINE D1 ANTAGONIST (IC50=1268 NANOMOLAR) HISTAMINE H1 ANTAGONIST (IC50=30 NANOMOLAR) ADRENERGIC ALPHA 1 RECEPTOR ANTAGONIST (IC50= 94 NANOMOLAR) ADRENARGIC ALPHA 2 RECEPTOR ANTAGONIST (IC50=271 NANOMOLAR) NO APPRECIABLE AFFINITY AT CHOLINERGIC MUSCARINIC AND BENZODIAZEPINE RECEPTORS (IC50 SUPERIOR TO 5000 NANOMOLAR) |
|
ATC code
N05AH04 |
|
Target TARGET 5-HYDROXYTRYPTAMINE 2 RECEPTOR D2 DOPAMINE RECEPTOR |
DrugCentral D(2) dopamine receptor UNIPROT P14416 DRD2 5-hydroxytryptamine receptor 2A UNIPROT P28223 HTR2A |
Download SDF file |
Dibenzo[b,f][1,4]thiazepine, 11-(1-piperazinyl)- Formula: C17H17N3S Calculated chemical properties: MW 295.41 NB_atoms 21 XLogP 3.13 PSA 25.567 NB_HD 1 NB_HA 3 fsp3 0.24 Lipinski(0=no;1=yes) 1 |
|
Other links: PubChem ChemicalProbes U.S. repository of Clinical Trials VigiAccess SIDER side effects ChemSynthesis Patent@SureChEMBL |